Should I Worry About My Cholesterol Ratio Result?: Bioavailability, Stack Synergies, and Lab-Backed Dosing

Should I Worry About My Cholesterol Ratio Result?

If you've just received a lipid panel and your eye landed on the cholesterol ratio figure, you're asking the right question. The ratio of total cholesterol to HDL (high-density lipoprotein) — or alternatively the LDL-to-HDL ratio — is consistently recognized by cardiovascular researchers as a more sensitive predictor of coronary heart disease risk than any single lipid value in isolation (Millán et al., Cardiovascular Diabetology 2009; PMID: 19646327).

So yes, it matters. But "worrying" without understanding what you're looking at rarely leads anywhere useful. This guide breaks down what the cholesterol ratio tells you, what it doesn't, and what targeted interventions — dietary, lifestyle, and supplemental — have real clinical data behind them.

---

Should I Worry About My Total Cholesterol Result?

Total cholesterol is the most commonly reported number on a lipid panel, and it's also one of the most misunderstood. A reading above 200 mg/dL is often flagged as borderline high, and above 240 mg/dL as high — but context changes everything.

Total cholesterol climbs when LDL rises (a genuine risk signal), but it also climbs when HDL rises — which is actually cardioprotective. A person with total cholesterol of 230 mg/dL but an HDL of 80 mg/dL may have a lower cardiovascular risk profile than someone with total cholesterol of 190 mg/dL and an HDL of 35 mg/dL.

This is precisely why the ratio framework was developed. The total cholesterol-to-HDL ratio divides your total cholesterol by your HDL number. The American Heart Association and most major cardiology bodies consider a ratio below 5.0 acceptable and below 3.5 optimal for most adults. A ratio above 5.0 begins to correlate with meaningfully elevated atherosclerotic risk.

LDL particle size adds another layer. Small, dense LDL particles are more atherogenic than large, buoyant ones — and standard lipid panels often don't distinguish between them. If your ratio is borderline and your provider offers advanced lipid testing (apolipoprotein B, LDL particle number, or Lp(a)), those additional markers can sharpen the picture considerably.

What moves total cholesterol in the wrong direction?

• Dietary saturated fat and trans fat intake
• Sedentary behavior
• Insulin resistance and metabolic syndrome
• Hypothyroidism (discussed below)
• Genetic hypercholesterolemia

---

Understanding the HDL-to-LDL Ratio: Clinical Ranges

The HDL-to-LDL ratio (HDL divided by LDL) is sometimes used as an inverse calculation — the higher the better. Below is a quick reference for interpreting common ratio metrics:

The triglyceride-to-HDL ratio deserves special mention: research published in Circulation found this ratio to be a strong surrogate for insulin resistance and a predictor of cardiovascular events independent of LDL levels (McLaughlin et al., Circulation 2005; PMID: 15851613). If your triglycerides are high and your HDL is low, that combination — even with a "normal" LDL — warrants attention.

---

The Thyroid Connection: Why TSH, Free T3, and Free T4 Affect Your Cholesterol Ratio

Here's something many people don't know: thyroid dysfunction is one of the most overlooked drivers of unfavorable cholesterol ratios. If you've been told to worry about your cholesterol and haven't had your thyroid checked, that's a gap worth closing.

Should I Worry About My TSH Result?

Thyroid-stimulating hormone (TSH) is the pituitary signal that tells your thyroid to produce hormones. When TSH is elevated — even in the subclinical range (TSH 2.5–10 mIU/L with normal T4) — the thyroid isn't keeping pace, and lipid metabolism slows. Multiple studies confirm that even subclinical hypothyroidism raises total cholesterol and LDL while blunting HDL (Razvi et al., Journal of Clinical Endocrinology & Metabolism 2008; PMID: 18270258).

The standard lab reference range for TSH is typically 0.4–4.0 mIU/L, but functional medicine practitioners often flag values above 2.5 mIU/L as worthy of monitoring, particularly in patients with lipid abnormalities, fatigue, or cold intolerance. If your TSH is creeping upward and your cholesterol ratio is worsening simultaneously, investigating thyroid function is clinically logical — not alarmist.

Should I Worry About My Free T4 Result?

Free T4 (thyroxine, the storage form of thyroid hormone) gives a direct measure of what the thyroid is secreting into circulation. Low-normal or below-range free T4, even with a borderline TSH, can impair the liver's ability to clear LDL from the bloodstream — because LDL receptor expression is partly regulated by thyroid hormone activity.

The normal range for free T4 is roughly 0.8–1.8 ng/dL depending on the lab. Values in the lower quartile of the reference range, particularly alongside other symptoms, may be worth discussing with a healthcare provider, especially if you're trying to understand a stubborn cholesterol ratio that doesn't respond to dietary change.

Should I Worry About My Free T3 Result?

Free T3 (triiodothyronine) is the metabolically active form of thyroid hormone — the version cells actually use. Conversion from T4 to T3 happens largely in the liver and gut, and poor conversion (low free T3 with normal T4) is increasingly recognized as a contributor to metabolic sluggishness, including lipid dysregulation.

Low free T3 has been independently associated with higher LDL cholesterol and lower HDL in euthyroid individuals — meaning people whose TSH appears normal but whose T3 conversion is suboptimal (Gao et al., Frontiers in Endocrinology 2020; PMID: 32117073). This explains why some patients with "normal" thyroid panels on paper still exhibit metabolic patterns consistent with hypothyroidism.

The takeaway: if your cholesterol ratio is abnormal, a complete thyroid panel — TSH, free T4, free T3, and ideally thyroid antibodies — is a diagnostically smart addition to your workup.

---

Evidence-Based Nutrients That Improve Cholesterol Ratios

Beyond thyroid optimization and lifestyle changes, several well-studied nutrients have demonstrated meaningful effects on lipid ratios in randomized controlled trials.

Omega-3 Fatty Acids (EPA + DHA)

Omega-3s are the most extensively studied lipid-modifying supplements. High-dose EPA and DHA (2–4g/day) consistently lower triglycerides by 15–30%, which directly improves the triglyceride-to-HDL ratio. A landmark meta-analysis of over 70 randomized trials confirmed their triglyceride-lowering efficacy without raising LDL in most populations (Mozaffarian & Wu, Journal of the American College of Cardiology 2011; PMID: 21875834).

EPA specifically has drawn attention for reducing LDL oxidation — a critical step in atherogenesis — and the REDUCE-IT trial demonstrated that high-dose icosapentaenoic acid (4g/day) reduced cardiovascular events by 25% in high-risk patients on statins (Bhatt et al., New England Journal of Medicine 2019; PMID: 30415628).

CoQ10 (Ubiquinol)

CoQ10 doesn't directly lower LDL, but it plays a critical supporting role in cardiovascular health, particularly for anyone on statin therapy. Statins deplete endogenous CoQ10 by blocking the same mevalonate pathway they use to reduce cholesterol synthesis. Low CoQ10 is associated with mitochondrial dysfunction in cardiac tissue. Supplementing with 200mg of ubiquinol (the reduced, more bioavailable form) has been shown to restore plasma CoQ10 levels more effectively than ubiquinone at equivalent doses.

Berberine

Berberine is an alkaloid derived from plants like barberry and goldenseal that activates AMPK pathways and upregulates hepatic LDL receptors — a mechanism similar to statin drugs. A meta-analysis of 27 randomized trials found berberine significantly reduced total cholesterol, LDL, and triglycerides compared to placebo (Pirillo & Catapano, Archives of Medical Science 2015).

Plant Sterols and Red Yeast Rice

Plant sterols (1.5–2g/day) competitively inhibit cholesterol absorption in the gut, reliably lowering LDL by 8–12% in clinical studies. Red yeast rice contains naturally occurring monacolins, including monacolin K (structurally identical to lovastatin), and has shown LDL reductions of 15–25% in several trials, though standardization varies significantly between products.

---

What This Means for Your Formula

If your lab results show an unfavorable cholesterol ratio — particularly an elevated total-to-HDL ratio, high triglycerides, or low HDL — a personalized approach to supplementation can meaningfully complement dietary and lifestyle changes.

Ones analyzes your bloodwork, wearable data, and health history through an AI health practitioner and builds a custom capsule formula calibrated to your specific findings. For cardiovascular-specific patterns, two ingredients are particularly relevant:

Omega-3 (EPA/DHA): Ones includes pharmaceutical-grade omega-3s dosed to clinical ranges — typically 2–4g EPA+DHA combined — which is the dose range supported by the REDUCE-IT trial and the Mozaffarian meta-analysis for meaningful triglyceride reduction. This isn't the 300mg found in most grocery store fish oil capsules.

CoQ10/Ubiquinol (200mg): Ones includes CoQ10 as ubiquinol at 200mg, which matches the dose range used in clinical studies for plasma CoQ10 restoration. This is especially relevant if your formula includes any ingredients that interact with the mevalonate pathway, or if you're already on statin therapy as directed by your physician.

For those whose cholesterol dysregulation appears to intersect with thyroid function, Ones' Thyroid Support system blend provides targeted micronutrient cofactors — including selenium and iodine — that support healthy T4-to-T3 conversion. If your AI analysis flags both lipid and thyroid markers as areas of focus, your formula may include both cardiovascular and thyroid-supportive ingredients within your 6 or 9-capsule daily plan, prioritized by what your data shows matters most.

Learn more about how omega-3 dosing affects cardiovascular risk markers and how thyroid health connects to metabolic function.

---

Key Takeaways

• The cholesterol ratio matters more than total cholesterol alone — the total-to-HDL ratio below 3.5 is considered optimal; above 5.0 signals meaningful cardiovascular risk.
• Total cholesterol can be misleading — a high number driven by high HDL is very different from one driven by high LDL or small dense LDL particles.
• Thyroid status directly affects lipid metabolism — elevated TSH, low free T4, or poor T4-to-T3 conversion can all worsen cholesterol ratios, even in people without a formal hypothyroidism diagnosis.
• Omega-3s at clinical doses (2–4g EPA/DHA) are among the most evidence-backed interventions for lowering triglycerides and improving the triglyceride-to-HDL ratio.
• CoQ10 as ubiquinol at 200mg supports mitochondrial and cardiovascular function, particularly relevant for individuals on lipid-lowering medications.
• Personalized lab analysis — the kind Ones uses — is the most efficient way to determine which combination of interventions applies to your specific lipid pattern rather than applying a one-size-fits-all cholesterol protocol.

This article is for educational purposes only. Consult a qualified healthcare provider before making changes to your supplement regimen, particularly if you are managing a diagnosed cardiovascular or thyroid condition or taking prescription medications.